SCHEMBL6489927

SCHEMBL6489927

CC(C)c1ccc2[nH]c3c(c2c1)/C(=N/N(C)C1=NCCN1)CC(c1ccccc1)C3

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.33
LMNA P02545 3/20 0.33
HSD17B10 Q99714 2/20 0.33
PIM1 P11309 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33
ADRA2A P08913 1/20 0.32
ADRA2B P18089 1/20 0.32
ADRA2C P18825 1/20 0.32
HTT P42858 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
TP53 P04637 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
ALDH1A1 P00352 1/20 0.31
PARP1 P09874 2/20 0.30
PARP2 Q9UGN5 2/20 0.30
TNKS2 Q9H2K2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6489930 1.00 HPGD (0.33) HPGDLMNAHSD17B10PIM1CLK4
SCHEMBL6489539 0.89 ALDH1A1 (0.40) HPGDLMNAHSD17B10PIM1CLK4
SCHEMBL6500356 0.88 PARP1 (0.36) HPGDLMNAHSD17B10PIM1CLK4
SCHEMBL6486879 0.80 MAPT (0.38) CLK4ADRA2AADRA2BADRA2CHTT
SCHEMBL6489941 0.80 NISCH (0.36) HPGDLMNAHSD17B10PIM1CLK4
SCHEMBL6487098 0.79 NISCH (0.32) ADRA2AADRA2BADRA2CHTTALDH1A1
SCHEMBL6487101 0.79 NISCH (0.32) ADRA2AADRA2BADRA2CHTTALDH1A1
SCHEMBL6495347 0.72 MAPT (0.35) HPGDLMNAHSD17B10PIM1CLK4
SCHEMBL7128314 0.72 MAPT (0.35) HPGDLMNAHSD17B10PIM1CLK4
SCHEMBL6489545 0.69 KMT2A (0.40) HPGDLMNAHSD17B10PIM1CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6951881-B2 (1-substituted-indol-3-yl) alkylidenehydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands WYETH (US) 2005-10-04 US disclosed